State of Wyoming’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Buy
+7,022
New +$142K 0.01% 1228
2026
Q1
Sell
-7,561
Closed -$202K 1797
2025
Q4
$202K Buy
7,561
+4,260
+129% +$110K 0.02% 963
2025
Q3
$88K Buy
3,301
+578
+21% +$14.9K 0.01% 1339
2025
Q2
$62.5K Sell
2,723
-2,137
-44% -$53K 0.01% 1459
2025
Q1
$141K Buy
+4,860
New +$155K 0.02% 1003
2024
Q2
Sell
-1,487
Closed -$65.3K 1654
2024
Q1
$65.3K Buy
1,487
+669
+82% +$34.6K 0.01% 1214
2023
Q4
$50.6K Sell
818
-524
-39% -$27.5K 0.01% 1295
2023
Q3
$61.7K Sell
1,342
-3,401
-72% -$186K 0.01% 1166
2023
Q2
$273K Buy
4,743
+3,748
+377% +$166K 0.08% 226
2023
Q1
$37.3K Sell
995
-2,840
-74% -$93.1K 0.01% 1185
2022
Q4
$107K Buy
3,835
+1,668
+77% +$48.4K 0.04% 698
2022
Q3
$61K Buy
2,167
+114
+6% +$3.72K 0.03% 903
2022
Q2
$71K Sell
2,053
-1,119
-35% -$39.9K 0.04% 716
2022
Q1
$114K Buy
3,172
+588
+23% +$16.7K 0.06% 501
2021
Q4
$60K Buy
+2,584
New +$52.8K 0.03% 996

Other funds holding AMPH

State of Wyoming's AMPH Position: Q2 2026 in Review

State of Wyoming opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 7,022 shares worth $142K. The stake represents 0.01% of the portfolio and ranks #1228 among its holdings. This is a return to the name: State of Wyoming previously reported a position in AMPH as recently as Q4 2025.

State of Wyoming first reported a position in AMPH in Q4 2021 and has held it in 15 quarters since. The position peaked at $273K in Q2 2023. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • State of Wyoming held 7,022 shares of Amphastar Pharmaceuticals worth $142K as of Q2 2026.
  • Amphastar Pharmaceuticals was a new State of Wyoming position in Q2 2026.
  • Amphastar Pharmaceuticals made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1228 holding.
  • State of Wyoming first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
  • State of Wyoming's Amphastar Pharmaceuticals position peaked at $273K in Q2 2023.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.